Modification of permeability transition pore arginine(s) by phenylglyoxal derivatives in isolated mitochondria and mammalian cells. Structure-function relationship of arginine ligands. 2005

Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
Helsinki Biophysics and Biomembrane Group, Institute of Biomedicine/Biochemistry, P.O. Box 63, University of Helsinki, Helsinki FIN-00014, Finland.

Methylglyoxal and synthetic glyoxal derivatives react covalently with arginine residue(s) on the mitochondrial permeability transition pore (PTP). In this study, we have investigated how the binding of a panel of synthetic phenylglyoxal derivatives influences the opening and closing of the PTP. Using both isolated mitochondria and mammalian cells, we demonstrate that the resulting arginine-phenylglyoxal adduct can lead to either suppression or induction of permeability transition, depending on the net charge and hydrogen bonding capacity of the adduct. We report that phenylglyoxal derivatives that possess a net negative charge and/or are capable of forming hydrogen bonds induced permeability transition. Derivatives that were overall electroneutral and cannot form hydrogen bonds suppressed permeability transition. When mammalian cells were incubated with low concentrations of negatively charged phenylglyoxal derivatives, the addition of oligomycin caused a depolarization of the mitochondrial membrane potential. This depolarization was completely blocked by cyclosporin A, a PTP opening inhibitor, indicating that the depolarization was due to PTP opening. Collectively, these findings highlight that the target arginine(s) is functionally linked with the opening/closing mechanism of the PTP and that the electric charge and hydrogen bonding of the resulting arginine adduct influences the conformation of the PTP. These results are consistent with a model where the target arginine plays a role as a voltage sensor.

UI MeSH Term Description Entries
D007425 Intracellular Membranes Thin structures that encapsulate subcellular structures or ORGANELLES in EUKARYOTIC CELLS. They include a variety of membranes associated with the CELL NUCLEUS; the MITOCHONDRIA; the GOLGI APPARATUS; the ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES. Membranes, Intracellular,Intracellular Membrane,Membrane, Intracellular
D007473 Ion Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. Membrane Channels,Ion Channel,Ionic Channel,Ionic Channels,Membrane Channel,Channel, Ion,Channel, Ionic,Channel, Membrane,Channels, Ion,Channels, Ionic,Channels, Membrane
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D008933 Mitochondrial Swelling An increase in MITOCHONDRIAL VOLUME due to an influx of fluid; it occurs in hypotonic solutions due to osmotic pressure and in isotonic solutions as a result of altered permeability of the membranes of respiring mitochondria. Giant Mitochondria,Megamitochondria,Mitochondrial Hypertrophy,Giant Mitochondrias,Hypertrophy, Mitochondrial,Megamitochondrias,Mitochondria, Giant,Mitochondrial Hypertrophies,Swelling, Mitochondrial
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D010658 Phenylglyoxal A reagent that is highly selective for the modification of arginyl residues. It is used to selectively inhibit various enzymes and acts as an energy transfer inhibitor in photophosphorylation.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein

Related Publications

Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
January 2002, The Journal of biological chemistry,
Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
June 1997, FEBS letters,
Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
May 1998, The Journal of biological chemistry,
Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
August 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
December 1998, Proceedings of the National Academy of Sciences of the United States of America,
Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
January 2012, Neural regeneration research,
Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
April 1998, Biophysical journal,
Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
September 2012, Journal of visualized experiments : JoVE,
Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
January 1989, Journal of enzyme inhibition,
Milena Johans, and Eva Milanesi, and Marina Franck, and Christoffer Johans, and Julius Liobikas, and Maria Panagiotaki, and Lucedio Greci, and Giovanni Principato, and Paavo K J Kinnunen, and Paolo Bernardi, and Paola Costantini, and Ove Eriksson
August 2018, The Journal of membrane biology,
Copied contents to your clipboard!